You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 5, May 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  Vignettes
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pyoderma Gangrenosum in a Patient With HTLV-III Antibody

Bennett K. Schwartz, MD; William E. Clendenning, MD; Lawrence G. Blasik, MD
Department of Dermatology Dartmouth-Hitchcock Medical Center Hanover, NH 03756; Dover, NH

Arch Dermatol. 1986;122(5):508-509.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Pyoderma gangrenosum (PG) is an uncommon cutaneous ulcerative disease of unknown causes.1 Human T-cell lymphotropic virus type III (HTLV-III) antibody has been isolated in individuals with acquired immunodeficiency syndrome (AIDS) or at risk for AIDS.2 Both conditions have been associated with quantitative and qualitative abnormalities in humoral and cell-mediated immunity. We herein report a case in which the two conditions coexist.

Report of a Case.—

A 23-year-old homosexual man was examined at Dartmouth-Hitchcock Medical Center, Hanover, NH, in March 1985 for a six-year history of recurrent episodes of bilateral lower-extremity ulcers. The lesions have begun as inflammatory nodules or pustules, which rapidly enlarge and ulcerate. The tender ulcers have violaceous, undermined, raised borders with beefy exudative bases. The lesions are slow to heal, granulating over several months. Over the years, the patient has been treated with a variety of agents, including systemic and topical antibiotics, . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.